Volume 43, Issue 22, Page 4 (15 November 2008)
8 of 22
PREVIEW
FULL TEXT
FULL-TEXT PDF (101 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The FDA statement can be found at www.fda.gov/medwatch/safety/2008/safety08.htm#bisphosphonates2. Serious or unexpected adverse events associated with bisphosphonates can be reported to the FDA's MedWatch program at 800-332-1088 or www.fda.gov/MedWatch/report.htm.
PII: S0029-7437(08)70683-9
doi:10.1016/S0029-7437(08)70683-9
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.